Assertio Therapeutics Inc Cash Flow-to-Debt Ratio
Assertio Therapeutics Inc cash flow-to-debt ratio. Assertio Therapeutics Inc (ASRT) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $8.56 Million could theoretically repay 0% of its total liabilities ($135.67 Million) in one year. Check cash flow quality index of Assertio Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Assertio Therapeutics Inc (1996–2025)
Cash flow-to-debt ratio of Assertio Therapeutics Inc from 1996 to 2025. Historical debt coverage capacity for Assertio Therapeutics Inc across 30 annual periods. Check total reinvestment intensity of Assertio Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Assertio Therapeutics Inc Cash Flow-to-Debt Ratio by Year (1996–2025)
Assertio Therapeutics Inc cash flow-to-debt ratio by year from 1996 to 2025. Year-by-year debt coverage analysis for Assertio Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Assertio Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | $-28.18 Million | $173.02 Million | ▼ -200.9% |
| 2024 | 0.16x | $26.41 Million | $163.65 Million | ▼ -51.7% |
| 2023 | 0.33x | $49.60 Million | $148.42 Million | ▼ -20.0% |
| 2022 | 0.42x | $78.60 Million | $188.19 Million | ▲ +1594.9% |
| 2021 | 0.02x | $5.52 Million | $224.13 Million | ▲ +109.3% |
| 2020 | -0.26x | $-65.57 Million | $247.76 Million | ▼ -237.3% |
| 2019 | 0.19x | $90.47 Million | $469.21 Million | ▲ +89.5% |
| 2018 | 0.10x | $72.50 Million | $712.53 Million | ▲ +42.2% |
| 2017 | 0.07x | $62.17 Million | $869.11 Million | ▲ +6.4% |
| 2016 | 0.07x | $65.50 Million | $974.55 Million | ▼ -51.0% |
| 2015 | 0.14x | $143.89 Million | $1.05 Billion | ▲ +185.1% |
| 2014 | -0.16x | $-55.92 Million | $346.62 Million | ▼ -714.0% |
| 2013 | 0.03x | $9.75 Million | $371.24 Million | ▲ +104.9% |
| 2012 | -0.54x | $-30.98 Million | $57.72 Million | ▼ -154.4% |
| 2011 | 0.99x | $57.65 Million | $58.45 Million | ▲ +2747.9% |
| 2010 | -0.04x | $-2.38 Million | $63.92 Million | ▼ -253.7% |
| 2009 | 0.02x | $1.84 Million | $75.86 Million | ▼ -55.2% |
| 2008 | 0.05x | $3.35 Million | $61.93 Million | ▼ -87.0% |
| 2007 | 0.42x | $14.66 Million | $35.12 Million | ▲ +220.4% |
| 2006 | -0.35x | $-27.70 Million | $79.91 Million | ▼ -171.7% |
| 2005 | 0.48x | $28.82 Million | $59.62 Million | ▲ +130.0% |
| 2004 | -1.61x | $-23.27 Million | $14.47 Million | ▲ +36.4% |
| 2003 | -2.53x | $-33.15 Million | $13.12 Million | ▼ -1585.4% |
| 2002 | -0.15x | $-4.44 Million | $29.59 Million | ▲ +87.6% |
| 2001 | -1.21x | $-12.40 Million | $10.22 Million | ▲ +24.4% |
| 2000 | -1.60x | $-6.65 Million | $4.15 Million | ▼ -437.5% |
| 1999 | -0.30x | $-3.94 Million | $13.22 Million | ▲ +86.9% |
| 1998 | -2.27x | $-2.50 Million | $1.10 Million | ▼ -3.3% |
| 1997 | -2.20x | $-1.10 Million | $500.00K | ▼ -285.0% |
| 1996 | -0.57x | $-400.00K | $700.00K | — |